Krilogy Financial LLC Makes New Investment in Centene Corporation $CNC

Krilogy Financial LLC purchased a new position in Centene Corporation (NYSE:CNC) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 52,786 shares of the company’s stock, valued at approximately $1,945,000.

A number of other hedge funds also recently made changes to their positions in the stock. Norges Bank bought a new position in Centene in the second quarter valued at $1,435,997,000. Packer & Co Ltd purchased a new position in shares of Centene in the 3rd quarter worth about $50,487,000. Worldquant Millennium Advisors LLC bought a new position in shares of Centene during the 2nd quarter valued at about $65,105,000. Vanguard Group Inc. raised its holdings in shares of Centene by 1.5% during the 2nd quarter. Vanguard Group Inc. now owns 58,396,605 shares of the company’s stock valued at $3,169,768,000 after buying an additional 869,706 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Centene in the 2nd quarter worth approximately $40,471,000. 93.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on CNC. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research note on Tuesday. Jefferies Financial Group lifted their target price on shares of Centene from $25.00 to $32.00 in a research report on Monday, November 3rd. Wall Street Zen upgraded shares of Centene from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research note on Wednesday, January 21st. Finally, TD Cowen boosted their target price on Centene from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Wednesday. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Centene currently has an average rating of “Hold” and an average target price of $41.50.

Key Stories Impacting Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Deutsche Bank raised its price target to $39 (from $32) while keeping a “hold” rating — the PT bump improves near‑term sentiment and likely helped buying interest. Deutsche Bank Boosts PT to $39
• Positive Sentiment: TD Cowen raised its price target to $38 (maintaining a “hold”) — another upward revision that supports investor confidence even if the rating stays neutral. TD Cowen Raises PT to $38
• Positive Sentiment: Media/analyst write‑ups (Zacks/MSN) profile Centene as a long‑term value stock — such coverage can attract buy‑and‑hold investors and bolster demand. Zacks: Top Value Stock
• Neutral Sentiment: Cantor Fitzgerald reaffirmed a “neutral” rating, leaving analyst guidance unchanged. Cantor Fitzgerald Reaffirms Neutral
• Neutral Sentiment: Argus and Morgan Stanley maintained “hold/neutral” stances — multiple holds suggest limited near‑term upside from analyst action alone. Argus Upgrade to Hold Morgan Stanley Maintains Hold
• Neutral Sentiment: Superior HealthPlan (a Centene company) launched a school program addressing social isolation — positive PR/ESG impact but unlikely to move near‑term earnings. PR: No One Eats Alone
• Negative Sentiment: Axios reports Centene is among insurers to receive subpoenas from a House panel — this introduces regulatory and legal risk that could weigh on the stock if the inquiry deepens. Axios: House Panel Subpoenas

Centene Stock Performance

NYSE:CNC opened at $40.43 on Thursday. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a quick ratio of 1.08, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. The firm’s fifty day simple moving average is $42.08 and its 200 day simple moving average is $36.18. The stock has a market cap of $19.87 billion, a P/E ratio of -2.97, a price-to-earnings-growth ratio of 0.87 and a beta of 0.48.

Centene (NYSE:CNC) last issued its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same period last year, the business posted $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, research analysts predict that Centene Corporation will post 6.86 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.